Cargando…
Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
Immunotherapy is a vital treatment for patients with cutaneous melanoma (CM), but effective predictors to guide clinical immunotherapy are lacking. Cuproptosis is a newly discovered mode of cell death related to tumorigenesis. Exploring the relationship between the mode of cuproptosis and the effect...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885583/ https://www.ncbi.nlm.nih.gov/pubmed/36717900 http://dx.doi.org/10.1186/s12967-023-03891-4 |